Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACAD · against 1,216 other Healthcare companies
Ranked #239 of 1,217 · scores higher than 80% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including ACAD · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | ACAD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 11.8% | 6.1% | 65% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 68.0% | 9.7% | 81% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 27.4% | 5.8% | 86% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 226 | 1.1B USD | 81 | 50 | |
| 226 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 271M SEK (≈$27M) |
| 81 |
| 41 |
| 239 | 231.7B JPY (≈$1.6B) | 80 | 61 |
| 239 | 5.9B HKD (≈$760M) | 80 | 59 |
| 239 | 3.5B USD | 80 | 75 |
| 239 | 5.0B THB (≈$141M) | 80 | 63 |
| 239 | 1.2B USD | 80 | 67 |
| 239 | Unavailable | 80 | 56 |
| 239 | 14.6B USD | 80 | 59 |